HEALTH

FDA strengthens warning about sleeping pill dangers

May 2, 2019, 8:10 AM
Certain commonly used sleeping pills will now contain a new boxed warning alerting patients to poss...
Certain commonly used sleeping pills will now contain a new boxed warning alerting patients to possible serious or life-threatening behaviors that may result from taking these drugs, the US Food and Drug Administration announced Tuesday. The move follows several reports of rare but serious injuries and deaths resulting from sleepwalking, sleep-driving and other complex behaviors while sleeping, such as unsafe use of a stove

(CNN) — Certain commonly used sleeping pills will now contain a new boxed warning alerting patients to possible serious or life-threatening behaviors that may result from taking these drugs, the US Food and Drug Administration announced Tuesday. The move follows several reports of rare but serious injuries and deaths resulting from sleepwalking, sleep-driving and other complex behaviors while sleeping, such as unsafe use of a stove.

Eszopiclone (Lunesta), zaleplon (Sonata) and zolpidem (Ambien, Ambien CR, Edluar, Intermezzo and Zolpimist) will require the new boxed warnings, which are the most prominent of FDA cautions, the agency said.

“These incidents can occur after the first dose of these sleep medicines or after a longer period of treatment, and can occur in patients without any history of these behaviors and even at the lowest recommended doses,” Acting Commissioner Dr. Ned Sharpless said in the statement.

The agency also says doctors should not prescribe these medicines to patients who have experienced such episodes after taking these drugs.

Millions of Americans use sleeping pills, according to a US Centers for Disease Control and Prevention report: About 4% of adults have used prescription sleep aids in the past month. More adult women (5%) use prescription sleep aids than adult men (3.1%), while white adults (4.7%) are more likely to use the pills than black (2.5%).

Not all sleep aids pose these risks, the FDA noted.

The labels of sleeping drugs that contain eszopiclone, zaleplon or zolpidem already include a warning, the agency said. Together, the new boxed warning and the new rule against prescribing to at-risk patients are intended to emphasize existing warnings while suggesting that the risk of injury and death is serious.

The FDA identified 66 reports of patients over the past 26 years who had taken either eszopiclone, zaleplon or zolpidem and then experienced serious injuries or death while not fully awake.

Accidental overdoses, falls, burns, near-drowning, extreme temperature exposures leading to loss of limb, self-inflicted gunshot wounds and suicide attempts were among the 46 non-fatal injuries; 20 deaths occurred due to carbon monoxide poisoning, drowning, falls, hypothermia, car crashes and suicide.

“Patients usually did not remember these events,” a drug safety communication from the FDA said. “The underlying mechanisms by which these insomnia medicines cause complex sleep behaviors are not completely understood.”

Pfizer, drug maker of Sonata; Sandoz, maker of Ambien; and Sunovion, maker of Lunesta, did not respond to requests for comment.

In 2013, the FDA required makers of sleeping pills with the active ingredient zolpidem to lower their recommended doses. At the time, researchers had found high blood levels of zolpidem in some patients the morning after they took doses affecting their cognitive skills, including their ability to drive.

The FDA said then that lower doses of zolpidem would cut down on morning-after blood levels. The agency also noted that the recommended dosages should be lower for women, because they don’t process zolpidem out of their systems as quickly as men, though doctors might also consider lowering doses for men. And patients using extended-release forms of these pills are at higher risk of next-morning impairment, according to the agency.

All patients should be notified about possible “morning after” risks, the FDA said at the time.

Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said Tuesday that the agency has monitored these drugs since they were approved: eszopiclone was approved in 2004, zaleplon in 1999 and zolpidem in 1992. “We’ll continue to monitor and evaluate these risks associated with insomnia medications and communicate with the public or consider further actions, as appropriate,” she said.

The-CNN-Wire
™ & © 2019 Cable News Network, Inc., a Time Warner Company. All rights reserved.

Today’s Top Stories

Health

Rabies in bats....
Waverly Golden

Utah health officials confirm three cases of rabies in bats

Three cases of rabies in bats have been confirmed in Utah. In each case, pets or humans were exposed and received treatment.
1 day ago
A Rite Aid logo is displayed on its store...
HALELUYA HADERO, AP Reporter

Amazon, Rite Aid cap purchase of emergency contraceptives

Retailers limiting purchases is standard practice that helps retailers prevent stockpiling and reselling at higher prices.
1 day ago
CDC reports monkeypox cases....
Waverly Golden

CDC confirms five monkeypox cases in Utah

SALT LAKE CITY — The U.S. Centers for Disease Control and Prevention, CDC, confirmed a total of five monkeypox cases in Utah Wednesday morning. According to the Utah Department of Health, four of the cases are located in Salt Lake County and one in Utah County. On Tuesday, the total number of cases statewide was […]
2 days ago
A crowd gathers in front of the Utah State Capitol on Friday, June 24, 2022, to protest the U.S. Su...
Becky Bruce

Different abortion law now in effect in Utah

A different abortion law is now in effect in Utah, and it bans abortions after 18 weeks of pregnancy. However, there are several exceptions to this law.
3 days ago
Rising temperatures across the country are putting the homeless at risk of heat-related death. Many...
Waverly Golden, Aimee Cobabe

Heat waves bring concerns for heat-related illnesses and the homeless population

Record-breaking heat waves have caused an abundance of heat-related deaths among the homeless.
3 days ago
IV bags hang in a room. Intermountain healthcare conducted a study on IV fluid....
Samantha Herrera

Intermountain Healthcare study finds “better” IV fluid treatment

Researchers with Intermountain Healthcare conducted a 15-month-long study to learn the effects of using an alternative IV fluid for patients.
3 days ago

Sponsored Articles

Tax Harassment...
Jordan Wilcox

The best strategies for dealing with IRS tax harassment | You have options!

Learn how to deal with IRS tax harassment. This guide will teach you how to stop IRS phone calls and letters, and how to handle an IRS audit.
spend a day at Bear Lake...
Bear Lake Convention and Visitors Bureau

You’ll love spending the day at Bear Lake | How to spend a day at Bear Lake

Bear Lake is a place that needs to be experienced. Spend a day at Bear Lake.
Curb Appeal...
Price's Guaranteed Doors

How to have the best of both worlds for your house | Home security and curb appeal

Protect your home and improve its curb appeal with the latest security solutions like beautiful garage doors and increased security systems.
Prescription opioids can be disposed of during National Prescription Take Back Day...
Know Your Script

Prescription opioid misuse | How to protect your family from the opioid epidemic

Studies have shown that prescription opioid misuse has increased since COVID-19. So what do you need to know about these opioids?
national heart month...
Intermountain Healthcare

National Heart Month: 5 Lifestyle Changes to Make Today to Keep You Heart Healthy

Heart disease is the leading cause of death for both men and women. One person dies every 36 seconds in the United States from cardiovascular disease
Joseph Smith Memorial Building...
Temple Square

The Joseph Smith Memorial Building is an icon of Salt Lake City | Why hosting an event at this beautiful location will make you a hero this year

Here's why hosting an event at the iconic Joseph Smith Memorial Building in downtown Salt Lake City will make you a hero this year.
FDA strengthens warning about sleeping pill dangers